A novel method of cell-specific mRNA transfection

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Delivery

Background:

• Existing protein delivery methods using streptavidin-protein A (ST-PA) fusion protein and monoclonal antibodies (mAbs) have been established.
• The need for targeted mRNA delivery into specific cell types for research and therapeutic applications is growing.

Purpose of the Study:

• To develop a novel, cell-specific mRNA transfection system.
• To enable targeted delivery of mRNA into specific cancer cells.
• To achieve high levels of transient protein expression via targeted mRNA delivery.

Main Methods:

• Development of a cell-specific mRNA transfection system utilizing streptavidin-protein A (ST-PA) fusion protein and monoclonal antibodies (mAbs).
• Complexation of in vitro transcribed, biotinylated, self-replicating Sindbis virus genomic RNA with ST-PA fusion protein and mAbs.
• Utilized cationic liposomes to prevent RNA degradation and enhance transfection efficiency in specific cancer cells.

Main Results:

• The developed complex successfully transfected a reporter gene into specific cancer cells in a mAb-dependent manner, particularly when using cationic liposomes.
• Even without cationic liposomes, the biotinylated mRNA, ST-PA fusion, and mAb complexes demonstrated transfection capabilities in certain cancer cell suspension cultures.
• Achieved high levels of transient protein expression in targeted cells.

Conclusions:

• A novel and effective cell-specific mRNA transfection system has been successfully developed.
• This system offers a targeted approach for introducing various mRNAs into specific cell types.
• The method facilitates high transient protein expression, paving the way for advanced research and potential therapeutic applications.